Literature DB >> 25990602

Therapeutic antibodies: Discovery, design and deployment.

Paul A Ramsland1, Andrew T Hutchinson2, Paul J Carter3.   

Abstract

Therapeutic antibodies have come of age with major progress being made in cancer, autoimmunity and chronic inflammation, as well as a wide range of other human diseases. Antibody engineering is further driving development of novel antibody formats and genetically modified cell-based therapies that harness the power of the immune system to progress cures in otherwise intractable human diseases. Nevertheless, there are still significant challenges ahead for basic and applied research relating to therapeutic antibodies. This special issue of the journal provides reviews and opinions that relate to the discovery, design and deployment of antibodies as therapeutics.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25990602     DOI: 10.1016/j.molimm.2015.05.004

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  5 in total

Review 1.  Pharmacokinetic de-risking tools for selection of monoclonal antibody lead candidates.

Authors:  Miroslav Dostalek; Thomayant Prueksaritanont; Robert F Kelley
Journal:  MAbs       Date:  2017-05-02       Impact factor: 5.857

2.  The tumor-inhibitory effectiveness of a novel anti-Trop2 Fab conjugate in pancreatic cancer.

Authors:  Yuan Mao; Xiaoying Wang; Feng Zheng; Changjun Wang; Qi Tang; Xiaojun Tang; Ning Xu; Huiling Zhang; Dawei Zhang; Lin Xiong; Jie Liang; Jin Zhu
Journal:  Oncotarget       Date:  2016-04-26

3.  Human C1q Induces Apoptosis in an Ovarian Cancer Cell Line via Tumor Necrosis Factor Pathway.

Authors:  Anuvinder Kaur; Sami H A Sultan; Valarmathy Murugaiah; Ansar A Pathan; Fatimah S Alhamlan; Emmanouil Karteris; Uday Kishore
Journal:  Front Immunol       Date:  2016-12-21       Impact factor: 7.561

4.  Structural basis of a novel heterodimeric Fc for bispecific antibody production.

Authors:  Hudie Wei; Haiyan Cai; Yuhao Jin; Pilin Wang; Qingqing Zhang; Yihui Lin; Weixiao Wang; Jinke Cheng; Naiyan Zeng; Ting Xu; Aiwu Zhou
Journal:  Oncotarget       Date:  2017-05-02

Review 5.  Immunotherapies: Exploiting the Immune System for Cancer Treatment.

Authors:  Jeffrey Koury; Mariana Lucero; Caleb Cato; Lawrence Chang; Joseph Geiger; Denise Henry; Jennifer Hernandez; Fion Hung; Preet Kaur; Garrett Teskey; Andrew Tran
Journal:  J Immunol Res       Date:  2018-03-14       Impact factor: 4.818

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.